Status:
UNKNOWN
Cologne Placenta Cohort (CPC)
Lead Sponsor:
Sarah Appel
Conditions:
Obesity, Maternal
Gestational Diabetes Mellitus in Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
Aim of the study was to determine if signaling pathways in placentas of mothers affected by overweight/obesity or by gestational diabetes are altered compared to placentas of a control group (normal w...
Eligibility Criteria
Inclusion
- singleton pregnancy
- BMI before pregnancy \>= 18
- with \& without gestational diabetes
- c-section at gestational week 35+0 until 41+6
Exclusion
- multiple pregnancy
- maternal serious internal disease
- infections before pregnancy (e.g. HIV, hepatitis B)
- pregnancy-associates diseases (e.g. gestoses, androgen insensitivity syndrome)
Key Trial Info
Start Date :
March 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
247 Patients enrolled
Trial Details
Trial ID
NCT05424965
Start Date
March 23 2018
End Date
December 31 2022
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany, 50931